1-(6-Methoxy-2-(methylthio)pyrimidin-4-yl)piperidin-4-ol

Catalog No.: 
ACTHKQ756
CAS No.: 
1353979-87-9
Molecular Formula: 
C11H17N3O2S
Molecular Weight: 
255.34
1-(6-Methoxy-2-(methylthio)pyrimidin-4-yl)piperidin-4-ol structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
100mg95%$260.00InquiryInquiry
250mg95%$580.00InquiryInquiry

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product Name1-(6-Methoxy-2-(methylthio)pyrimidin-4-yl)piperidin-4-ol
IUPAC Name1-(6-methoxy-2-(methylthio)pyrimidin-4-yl)piperidin-4-ol
Molecular FormulaC11H17N3O2S
Molecular Weight255.34
SMILESOC1CCN(C2=NC(SC)=NC(OC)=C2)CC1
InChI KeyDUMCPXMQYBPACG-UHFFFAOYSA-N
Synonym1-(6-Methoxy-2-(Methylthio)pyriMidin-4-yl)piperidin-4-ol;1-(6-Methoxy-2-Methylsulfanyl-pyriMidin-4-yl)-piperidin-4-ol;4-Piperidinol, 1-[6-methoxy-2-(methylthio)-4-pyrimidinyl]-
CAS No.1353979-87-9

Safety Data

Pictogram
Harmful or irritant
Signal Word
Warning
Hazard Statement(s)
H302-H315-H319
Precautionary Statement(s)
P264-P270-P280-P301+P312+P330-P302+P352-P305+P351+P338-P332+P313-P337+P313-P362+P364-P501

Synthetic Route by SureRoute

1. ACTHKQ756 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. ACQVKH312 route compound structure diagram
    ACQVKH3121184-54-9In Stock
  4. Then
  5. ACTHKQ756 route product structure diagram
    ACTHKQ7561353979-87-9
Inquiry

2. ACTHKQ756 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Then
  3. ACTHKQ756 route product structure diagram
    ACTHKQ7561353979-87-9
Inquiry

3. ACTHKQ756 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Then
  3. ACTHKQ756 route product structure diagram
    ACTHKQ7561353979-87-9
Inquiry

Comments (0)